Skip to main content

Dr. Sulman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sulman's full profile

Already have an account?

  • Office

    560 1st Ave
    Fl 2
    New York, NY 10016
    Phone+1 646-501-8900
    Fax+1 646-501-8904

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2004 - 2008
  • Albert Einstein Medical Center
    Albert Einstein Medical CenterInternship, Transitional Year, 2003 - 2004
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 2003

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2018 - 2026
  • TX State Medical License
    TX State Medical License 2008 - 2025
  • American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Journal Articles

  • BCAT1 and miR-2504: Novel Methylome Signature Distinguishes spindle/desmoplastic Melanoma from Superficial Malignant Peripheral Nerve Sheath Tumor  
    Erik P Sulman, Matija Snuderl, George Jour, Phyu P Aung, Nature
  • A Co-Clinical Radiogenomic Validation Study - Conserved Magnetic Resonance Radiomic Appearance of Periostin Expressing Glioblastoma in Patients and Xenograft Models  
    Sanjay K Singh, Ashok J Kumar, Rivka R Colen, Gregory N Fuller, Frederick F Lang, Erik P Sulman, Clinical Cancer Research
  • Cell Surface Notch Ligand DLL3 Is a Therapeutic Target in Isocitrate Dehydrogenase Mutant Glioma  
    John G Golfinos, Daniel P Cahill, Erik P Sulman, David Zagzag, Clinical Cancer Research

Lectures

  • Predictive Molecular Biomarkers: Enriching Clinical Trial Populations for Glioblastoma 
    2013 Annual Meeting, Chicago, Illinois, USA
  • Predictive Molecular Biomarkers: Enriching Clinical Trial Populations for Glioblastoma 
    American Society of Clinical Oncology, 2013 Annual Meeting, Chicago, Illinois, USA

Press Mentions

  • Novocure Announces Strategic Alliance with NYU Grossman School of Medicine for Preclinical and Clinical Research
    Novocure Announces Strategic Alliance with NYU Grossman School of Medicine for Preclinical and Clinical ResearchOctober 29th, 2020
  • NYU Langone Health Launches New Molecular Assay to Identify Patients with Brain Tumors
    NYU Langone Health Launches New Molecular Assay to Identify Patients with Brain TumorsOctober 24th, 2019
  • How a Brain Tumor Taught Me to Embrace Myself
    How a Brain Tumor Taught Me to Embrace MyselfDecember 6th, 2017
  • Join now to see all